-
-
-
-
-
-
-
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2024
-
-
-
-
-
-
-
Form 8-K Summit Therapeutics Inc. For: Mar 17
-
-
-
-
-
-
-
Form S-3/A Summit Therapeutics Inc.
-
-
-
-
-
-
-
Summit Therapeutics Announces $100 Million Rights Offering
-
-
-
-
-
-
-
Summit Therapeutics Announces Topline Results for Phase III Ri-CoDIFy Study for C. Difficile Infection
-
-
-
-
-
-
-
Form 6-K Summit Therapeutics plc For: Aug 19
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

